Gleevec News and Research

RSS
Gleevec is a drug used to treat different types of leukemia and other cancers of the blood, gastrointestinal stromal tumors, skin tumors called dermatofibrosarcoma protuberans, and a rare condition called systemic mastocytosis. It is also being studied in the treatment of other types of cancer. Gleevec blocks the protein made by the bcr/abl oncogene. It is a type of tyrosine kinase inhibitor. Also called imatinib mesylate and STI571.
Two more drugs added to Medicare demonstration program

Two more drugs added to Medicare demonstration program

Stanford researchers identify leukemia stem cells

Stanford researchers identify leukemia stem cells

Identification of PIK3CA as an oncogene associated with brain cancers opens the door to new screening processes

Identification of PIK3CA as an oncogene associated with brain cancers opens the door to new screening processes

New compound that is designed to overcome Gleevec resistance

New compound that is designed to overcome Gleevec resistance

Chemotherapy agents as well as the newest biologic and targeted cancer therapy drugs, can harm a patient’s heart

Chemotherapy agents as well as the newest biologic and targeted cancer therapy drugs, can harm a patient’s heart

50,000 people in the U.S. with cancer, multiple sclerosis, rheumatoid arthritis or hepatitis C will be eligible for a Medicare drug lottery

50,000 people in the U.S. with cancer, multiple sclerosis, rheumatoid arthritis or hepatitis C will be eligible for a Medicare drug lottery

Tommy G. Thompson has announced a new Medicare program that will save seniors and the disabled substantial money

Tommy G. Thompson has announced a new Medicare program that will save seniors and the disabled substantial money

SU11248 proves effective in the treatment of gastrointestinal stromal tumors

SU11248 proves effective in the treatment of gastrointestinal stromal tumors

Tumour suppressor gene family may be key to new colon cancer drugs

Tumour suppressor gene family may be key to new colon cancer drugs

Drug combo effective for advanced breast cancer

Drug combo effective for advanced breast cancer

Developing smart drugs

Developing smart drugs

Mutation of a gene involved in non-small cell lung cancer linked to drug effectiveness

Mutation of a gene involved in non-small cell lung cancer linked to drug effectiveness

New gene presents a potent new target for breast cancer therapy

New gene presents a potent new target for breast cancer therapy

St. John’s wort may interfere with cancer-fighting drug’s ability to prevent relapse in leukemia patients

St. John’s wort may interfere with cancer-fighting drug’s ability to prevent relapse in leukemia patients

New therapies that may treat cancers

New therapies that may treat cancers